Drug profile · INN
cantharidin
YCANTH
cantharidin (YCANTH) is an FDA-listed pharmaceutical active ingredient. Associated with Verrica Pharmaceuticals. Route of administration: topical. Current US regulatory status: approved.
Drug details — cantharidin
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 7
- Programs
- 3
- Data quality
- 0.89
Quick answer
cantharidin (YCANTH) is an FDA-listed pharmaceutical active ingredient. Associated with Verrica Pharmaceuticals. Route of administration: topical. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related patents
-
US 12290651
Devices and methods for the treatment of body surface disorders
granted -
US 12233042
Treatment of cutaneous disorders
granted -
US 12221452
Synthesis of cantharidin
granted -
US 11168091
Quantification and preparation of pharmaceutical grade cantharidin
granted -
US 11147790
Treatment of cutaneous disorders
granted -
US 11052064
Compositions, methods and systems for the treatment of cutaneous disorders
granted -
US 10745413
Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives
granted
Frequently asked questions
What is cantharidin?
cantharidin (YCANTH) is an FDA-listed pharmaceutical active ingredient. Associated with Verrica Pharmaceuticals. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for cantharidin?
YCANTH is a marketed brand name for cantharidin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cantharidin?
cantharidin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.